Comparison of the expression of fibrosis‐associated genes in glomeruli after renal transplantation between conventional cadaveric and non‐heart‐beating donors

The main difference between cadaveric heart‐beating donors and non‐heart‐beating donors (NHBDs) is the degree of warm ischaemia to which the kidney is subjected. This study was designed to see if this affected the expression of fibrosis‐associated genes in the early period after transplantation.

[1]  A. Kanematsu,et al.  Long-term Renal Function In Non-heart-beating Donor Kidney Transplantation: A Single-center Experience1 , 1998 .

[2]  M. Nicholson,et al.  Renal allograft survival can be predicted by histomorphometric assessment of extracellular matrix in 6-month protocol biopsies. , 1998, Transplantation proceedings.

[3]  J. Pringle,et al.  Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA. , 1998, BioTechniques.

[4]  I. Roberts,et al.  Is persistent TGFbeta1 expression the mechanism responsible for chronic renal allograft loss? , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  D. Gjertson,et al.  Transplantation of kidneys from donors whose hearts have stopped beating. , 1998, The New England journal of medicine.

[6]  M. Furue,et al.  Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. , 1997, The Journal of investigative dermatology.

[7]  L. Sugar,et al.  alpha-smooth muscle actin and collagen deposition in dysfunctional renal transplants. , 1997, Transplantation.

[8]  J. Pringle,et al.  AMPLIFICATION OF SPECIFIC mRNA FROM A SINGLE HUMAN RENAL GLOMERULUS, WITH AN APPROACH TO THE SEPARATION OF EPITHELIAL CELL mRNA , 1996, The Journal of pathology.

[9]  L. Paul.  Chronic renal transplant loss. , 1995, Kidney international.

[10]  E. Heineman,et al.  Retrospective analysis of the outcome of transplantation of non-heart-beating donor kidneys. , 1995, Transplantation proceedings.

[11]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[12]  G. Murphy,et al.  Matrix metalloproteinases and their inhibitors. , 1992, Acta orthopaedica Scandinavica. Supplementum.

[13]  M. Schwartz,et al.  Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection. , 1992, Laboratory investigation; a journal of technical methods and pathology.